BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 943180)

  • 1. Reactivity of fibrinogen and fibrinopeptide A containing fibrinogen fragments with antisera to fibrinopeptide A.
    Canfield RE; Dean J; Nossel HL; Butler VP; Wilner GD
    Biochemistry; 1976 Mar; 15(6):1203-9. PubMed ID: 943180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemical studies of human fibrinopeptide A using synthetic peptide homologues.
    Wilner GD; Nossel HL; Canfield RE; Butler VP
    Biochemistry; 1976 Mar; 15(6):1209-13. PubMed ID: 1252441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of antisera to human fibrinopeptide A used in clinical fibrinopeptide A assays.
    Nossel HL; Butler VP; Wilner GD; Canfield RE; Harfenist EJ
    Thromb Haemost; 1976 Feb; 35(1):101-9. PubMed ID: 60791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reaction of plasmic degradation products of fibrinogen in the radioimmunoassay of human fibrinopeptide A.
    Budzynski AZ; Marder VJ; Sherry S
    Blood; 1975 Jun; 45(6):757-68. PubMed ID: 1168512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay of human fibrinopeptide B and kinetics of fibrinopeptide cleavage by different enzymes.
    Bilezikian SB; Nossel HL; Butler VP; Canfield RE
    J Clin Invest; 1975 Aug; 56(2):438-45. PubMed ID: 50328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monoclonal antibody with ability to distinguish between NH2-terminal fragments derived from fibrinogen and fibrin.
    Kudryk B; Rohoza A; Ahadi M; Chin J; Wiebe ME
    Mol Immunol; 1983 Nov; 20(11):1191-200. PubMed ID: 6656769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dimeric Aalpha chain composition of dysfibrinogenemic molecules with mutations at Aalpha 16.
    Meh DA; Siebenlist KR; Galanakis DK; Bergtrom G; Mosesson MW
    Thromb Res; 1995 Jun; 78(6):531-9. PubMed ID: 15714754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical studies of antisera to human fibrinopeptide-B.
    Butler VP; Weber DA; Nossel HL; Tse-Eng D; LaGamma KS; Canfield RE
    Blood; 1982 May; 59(5):1006-12. PubMed ID: 6176283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Habutobin recognizes Thr(7) in the sequence of fibrinopeptide A of rabbit fibrinogen.
    Nejime T; Kinjoh K; Nakamura M; Hanashiro K; Sunagawa M; Eguchi Y; Kosugi T
    Toxicon; 2000 Aug; 38(8):1029-41. PubMed ID: 10708795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of fibrinopeptide A in human blood.
    Nossel HL; Yudelman I; Canfield RE; Butler VP; Spanondis K; Wilner GD; Qureshi GD
    J Clin Invest; 1974 Jul; 54(1):43-53. PubMed ID: 4600045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disulfide-linked cyanogen bromide peptides of bovine fibrinogen. II. Isolation and sequence analysis of the chain constituents from the amino terminal region.
    Timpl R; Fietzek PP; Wachter E; Van Delden V
    Biochim Biophys Acta; 1977 Feb; 490(2):420-9. PubMed ID: 836881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence of release of fibrinopeptide A from fibrinogen molecules by thrombin or Atroxin.
    Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
    J Lab Clin Med; 1995 Mar; 125(3):384-91. PubMed ID: 7897305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary structure of human fibrinogen and fibrin. Structural studies on NH2-terminal part of B beta chain.
    Hessel B; Makino M; Iwanaga S; Blombäck B
    Eur J Biochem; 1979 Aug; 98(2):521-34. PubMed ID: 158526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of a monoclonal antibody for the NH2-terminal region of fibrin.
    Kudryk B; Rohoza A; Ahadi M; Chin J; Wiebe ME
    Mol Immunol; 1984 Jan; 21(1):89-94. PubMed ID: 6200769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunochemical determination of conformational equilibria for fragments of the B beta chain of fibrinogen.
    Nagy JA; Meinwald YC; Scheraga HA
    Biochemistry; 1985 Feb; 24(4):882-7. PubMed ID: 2581607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of forms of fragment E with differing thrombin-binding properties during digestion of fibrinogen by plasmin.
    Goodwin CA; Kakkar VV; Scully MF
    Biochem J; 1992 Feb; 281 ( Pt 3)(Pt 3):613-8. PubMed ID: 1531588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonrandom catabolism of proteins in the formation of antigenic peptide fragments.
    Thomas DW; Schauster JL; Hoffman MD; Wilner GD
    J Immunol; 1985 Aug; 135(2):1259-63. PubMed ID: 3874235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical studies on human fibrinogen and its fragments. Cross-reactivity of NH2-terminal "Disulfide Knot" and related structures as determined by radioimmunoassay.
    Kudryk B; Reuterby J; Blombäck B
    Eur J Biochem; 1974 Jul; 46(1):141-7. PubMed ID: 4136797
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation and partial structural characterization of an equine fibrinogen CNBr fragment that exhibits immunologic cross-reactivity with an A alpha-chain cross-linking region of human fibrinogen.
    Sobel JH; Thibodeau CA; Kolks MA; Canfield RE
    Biochemistry; 1990 Sep; 29(38):8907-16. PubMed ID: 2271566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinopeptide A and the phosphate content of fibrinogen in venous thromboembolism and disseminated intravascular coagulation.
    Leeksma OC; Meijer-Huizinga F; Stoepman-van Dalen EA; van Ginkel CJ; van Aken WG; van Mourik JA
    Blood; 1986 May; 67(5):1460-7. PubMed ID: 3697510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.